CN1981865A - Formula and usage for treating acne - Google Patents
Formula and usage for treating acne Download PDFInfo
- Publication number
- CN1981865A CN1981865A CN 200510107283 CN200510107283A CN1981865A CN 1981865 A CN1981865 A CN 1981865A CN 200510107283 CN200510107283 CN 200510107283 CN 200510107283 A CN200510107283 A CN 200510107283A CN 1981865 A CN1981865 A CN 1981865A
- Authority
- CN
- China
- Prior art keywords
- preparation
- cicatrix
- treatment
- hyaluronidase
- massage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A medicine for treating scar is composed of three components which are mixed before it is applied. It is proportionally prepared from hyaluronidase, lactose, azoanthracene, purified water, triamcinolone, refined lavenda oil, and ethyoxylated hydrogenated lanolin.
Description
Technical field
The invention belongs to the pharmaceutical preparation of medical field treatment cicatrix, relate in particular to and use a kind ofly, be equipped with the formed pharmaceutical preparation of auxiliary agent by biological product hyaluronidase, Garden lavender quintessence oil, Triamcinolone Acetonide compatibility.Have the sugar of influence and protein metabolism, strengthen gluconeogenesis, impel protein to decompose, metabolism strengthens, disturb the mechanism of fibroplasia, people's skin is hindered the keloid of fibrin hyperplasia that face causes and the formed local eminence of collagen fiber over-deposit, hard, color flushing, the sense of tool sufferings because of operation, burn, scald and accidental injury, thin out red, the better Therapeutic Method of removing sufferings sense therapeutical effect of flat, softening, color is arranged again.
The mechanism of cicatrization mainly is the over-deposit of fibrin hyperplasia and collagen fiber and forming.Because collagen is synthetic and the imbalance of degraded, the appearance of mucopolysaccharide, and the propagation of muscle fiber cell unusually causes local eminence, and is hard, color flushing, sufferings.It organizes particularly compact tough and tensile, and the clothes compressing also can cause the sufferings symptom.If scratching and can further promote, patient the hypertrophy of cicatrix causes vicious cycle.
The formation of cicatrix is to lack protection etc. because wound surface lacks the skin of regulatory mechanism and healing in agglutination, thereby causes the generation of cicatrix.The important pathological change of hypertrophy cicatrix is blood vessel, collagen fiber hypertrophy, arrangement disorder, and very itching of skin is in the scar tissue due to wall of micrangium and the peripheral termination of nerve anoxia thereof, rather than the teleneuron irriate of skin surface causes.
At present, the method for treatment cicatrix is commonly used surgery alone excision, freezing or laser therapy, Triamcinolone Acetonide part
90Ointment or ointment that strontium is applied ointment or plaster treatment, operation or the deep x ray radiotherapy of electron ion postoperative and contained Triamcinolone Acetonide are smeared.As a result, surgery alone excision, freezing or laser therapy, 100% recurrence.What have also causes skin lesion, or local pain, and curative effect is undesirable. and simple with the Triamcinolone Acetonide local injection or contain Triamcinolone Acetonide ointment or ointment is smeared, can only be the disease controlling development, mitigation symptoms is difficult for recovery from illness.
90Strontium is applied ointment or plaster the treatment effective percentage less than 40%, and operation or the radiotherapy of electron ion postoperative deep x ray are though the effective percentage height brings in various degree injury to human body.Simultaneously, can not use to privileged sites such as breast line, child and near not giving birth to patient's reproductive system.Otherwise, will have serious consequences.
Summary of the invention
The purpose of this invention is to overcome the deficiencies in the prior art, and employing modern medical theory and clinical summary, can influence sugar and protein metabolism in extensive screening, strengthen gluconeogenesis, impel protein to decompose, metabolism strengthens, disturb on the basis of fibroplasia mechanism, and provide a kind of according to biological product hyaluronidase and Triamcinolone Acetonide compatibility, carry the pharmaceutical preparation of penetrating agent Ah assistant's anthracene and auxiliary agent, to people's skin because of operation, burn, fibrin hyperplasia and the formed local eminence of collagen fiber over-deposit that face causes hindered in scald and accidental injury, hard, the keloid of color flushing tool sufferings sense has again flat, softening, color is thin out red, remove the medicine of the effect of sufferings sense, make it reach economical and practical, safe and efficient, easy to use purpose.
The object of the present invention is achieved like this, mixed by at least a biological product hyaluronidase, a kind of glucocorticoid Triamcinolone Acetonide and a kind of Chinese herbal medicine extract Garden lavender quintessence oil and auxiliary material.Its preparation umber is: hyaluronidase 1000
IULactose 600mg, Ah assistant's anthracene 100mg, pure water 10mil, Triamcinolone Acetonide 40mg Garden lavender quintessence oil 2000mg.Ethoxylation hydrogenated lanolin 20g makes A, B, C preparation respectively.
Compare with existing similar technology, the invention has following good effect:
1 the present invention is from the deficiency of present treatment cicatrix common method, it is first-selected selecting hyaluronidase for use, be because hyaluronidase extensively is present in the acid mucopolysaccharides macromolecular substances in people and the animal connective tissue, bring into play water conservation in vivo, osmotic pressure is regulated, keep tissue morphology, lubricated, mechanical function and important physical functions such as the gentle blow stress of diffusion barrier.Treat recovery from illness after a year, follow up a case by regular visits to after 2 years and do not see recurrent cases.
Its mechanism is to contain a large amount of carboxyls and hydroxyl in the hyaluronidase molecule, forms intramolecularly and intermolecular hydrogen bonding in aqueous solution.This makes it have powerful water retention, can be in conjunction with more than 1000 times water itself; Simultaneously, when higher concentration,, have significant viscoelasticity again, play the effect of softening cicatrix because its intermolecular interaction forms three grades of complicated network structure.
Hyaluronidase is the main component that constitutes extracellular matrix and intercellular substance, thereby participates in the regulation and control of cell internal and external exchange directly, the filter effect of performance physics and molecular information.Secondly the physiological function of hyaluronidase is different because of the molecular weight size.Macromolecule hyaluronidase pair cell moves, propagation, and differentiation and phagocytic function have inhibitory action, and the hyaluronidase of small-molecular weight then has facilitation.And the good affinity that utilizes itself and human body strengthens the therapeutic effect of medicine as carrier.
Hyaluronidase has the promotion healing, inflammation is had the effect that suppresses and prevent adhesion wound, for overcoming the limitation that natural hyaluronidase is easy to degrade at human body, it is carried out compound compatibility, carry Triamcinolone Acetonide, Ah assistant's anthracene, the hyaluronidase behind the compatibility can design administration time as required, strengthens the therapeutic effect of medicine, direct regulation and control, directed regularly administration.Can also utilize the acceptor selection of hyaluronidase, the medicine location is discharged.Can fully recover with its treatment cicatrix.Be difficult for recurrence.
But,, promptly lose activity rapidly under the room temperature because its character is extremely not latent fixed.Its aqueous solution is preserved during at 0 ℃ more stable in (PH4.0～7.6).So, must take special measure could guarantee its activity.Get a desired effect, ensure that the method for hyaluronidase activity will be the key point of success or not.The present invention adopts full pressed powder that hyaluronidase is made solid preparation, faces with before being dissolved in the special solvent, has both avoided hyaluronidase also to overcome the loss of activity that hyaluronidase causes because of being heated in the unstability in the aqueous solution in the preparation process.
The Triamcinolone Acetonide tool influences sugar and protein metabolism, strengthens gluconeogenesis, impels protein to decompose, and metabolism strengthens, and disturbs the mechanism of fibroplasia, and the synthetic effect of the fine microcell DNA of the cicatrix of inhibition is arranged.That the keloid that people's skin is hindered fibrin hyperplasia that face causes and the formed local eminence of collagen fiber over-deposit, hard, color flushing, the sense of tool sufferings because of operation, burn, scald and accidental injury has again is flat, softening, thin out red, the effect of removing the sufferings sense of color.
Garden lavender quintessence oil tool heals a wound, the function of fatigue alleviating.More the scar effect of smoked farming grass is derived from the characteristic of its activating cell, because it can promote cell regeneration, the secretion of balance skin oil and fat can accelerate to secrete the growth of the one-tenth fiber stem cell of collagen protein, so for the scar of skin good healing effect is arranged.
Ah assistant's anthracene is a penetrating agent, can accelerate the speed of medicine transdermal and non-stimulated to skin.Be characterized in all having better short running to use to many hydrophilic, lipophilic medicines.Its mechanism is that keratodermatitis cell membrane bits are increased, and biolipid plasma membrane discontinuity is increased, and lipoids produces irregular arrangement and dissolves the purpose that the skin lipoids reaches increases drug absorption in the keratodermatitis by making.Its skin penetration effect to medicine is quite strong.Medicine absorbs through skin owing to have the bar of avoiding first pass effect, but constant speed release medicine and reduce distinct advantages such as about thing untoward reaction, and the TTS of Ah assistant's anthracene (through transdermal therapeutic system) is stronger to the Triamcinolone Acetonide effect.
2. harmless to skin, local painless.Select hyaluronidase, Triamcinolone Acetonide, additive compatibility for use, to the skin avirulence, non-corrosiveness, nonirritant can not cause skin lesion and local pain.
3. be applicable to each position of whole body, easy to use.Select different auxiliary agents for use, make different preparations respectively.Different parts can select for use different dosage form to use.
4. use scar breath preparation for treating to fully recover after 1 year, follow up a case by regular visits to after 2 years and do not see recurrent cases.
The specific embodiment
＜one 〉. embodiment. make A, B, C preparation respectively:
A preparation: hyaluronidase 1000IU
Lactose 600mg
Make tablet
B preparation: Ah assistant's anthracene 100mg
Pure water 10mil.
Make the suspendible special solvent
C preparation: Triamcinolone Acetonide 1000mg
Garden lavender quintessence oil 2000mg
Ah assistant's anthracene 100mg
Ethoxylation hydrogenated lanolin 20g.
Make emulsifiable paste
＜two 〉, test period: on June 9th, 2003
＜three 〉, the clinical data EXPERIMENTAL DESIGN: select outpatient service keloid patient 87 examples, wherein, male 50 examples, women 37 examples, the age was at 12 years old～60 years old.Skin lesion area diameter≤1cm40 example, 1cm～5cm25 example, 6cm～15cm22 example.Site of pathological change: women's head-ornaments portion 20 examples, trunk 25 examples, extremity 12 examples, abdominal part 30 examples, the course of disease 1 month-12 years.Be divided into 1 treatment group and 2 matched groups at random;
1 group of 44 example is scar breath preparation for treating group.
2 group of 43 example is matched group, and simple the employing removes to pacify relaxed and comfortable injection, partial closure's treatment of injection in every month.
Concrete grammar: the 1st group of patient uses the scar breath
Earlier scar is ceased the A preparation be dissolved in treat in the B preparation to dissolve fully after, solution directly is applied to the cicatrix wound surface, then, use manual massage, usefulness refers to that the strength of abdomen, palm pushes repeatedly at the coating place and rotate poking meridian method.Massage or push more than 15 minutes after each medication.Then, again scar is ceased the C preparation and be applied to the cicatrix wound surface, use manual massage, push repeatedly at the coating place and rotate poking meridian method with the strength that refers to abdomen, palm.Massage or push more than 15 minutes after each medication, be administered once every day, and consumption is decided on the cicatrix area.
The simple employing of matched group patient removes to pacify relaxed and comfortable injection, and partial closure's smelting of injection in every month is treated, and consumption is a foundation with the cicatrix size, adds during injection to use lignocaine, and amount ratio is 1: 3.Select for use common 2ml syringe to extract medicinal liquid, the patient sets position, routine disinfection skin, and injection needle is parallel thrusting in the keloid in the cicatrix edge, and suitably pressurization injection medicinal liquid to cicatrix color bleaches.Pathological changes area the greater can adopt limit inserting needle marginal not to penetrate, and limit withdraw of the needle marginal not is penetrated and many injection points multi-method injection, till being bonded to whole cicatrix and bleaching with point, face.Partial closure's therapy is implemented by the treatment doctor, and first massage is carried out under physician guidance, after massage voluntarily.3 months is a course of treatment, treats after 6 months, 9 months, 1 year and observes localized variation, judges clinical efficacy, follows up a case by regular visits to after 9 days June in 2005 again.
＜four 〉, curative effect determinate standard (1) recovery from illness: the cicatrix softness, calm down, basic the same with normal skin, the cicatrix pain transference cure of itching, the diseased region functional rehabilitation is not recurring after the treatment; (2) take a turn for the better: skin lesion flat soft, cicatrix is slightly swelled, thicken, little pain of itching; (3) invalid: cicatrix is still swelled, and after increasing, still has the pain symptom of itching;
＜five 〉, result: see the following form
| Use medicine and dosage form | Cure rate (example) | Take a turn for the better (example) | Invalid (example) | Cure rate (%) | Effective percentage (%) | |
| Treatment group matched group | Scar breath preparation Triamcinolone Acetonide injection | 42 17 | 2 11 | 15 | 95 40 | 100 65 |
Show in the table that treatment group cure rate is 95%, the matched group cure rate is 40%, learns by statistics and handles (X
2Check), two groups have highly significant difference, and utmost point significance meaning is arranged: treatment group effective percentage is 100%, and the matched group effective percentage is 65%, handles (X2 check) through learning by statistics, and two groups have highly significant difference, and utmost point significance meaning is arranged.
On March 9th, 2005 followed up a case by regular visits to later on, treatment group recovery from illness and take a turn for the better do not see recurrent cases, the matched group 15 example recurrences in 17 examples of fully recovering, 8 example recurrences in 11 examples that take a turn for the better.
Claims (4)
1. pharmaceutical preparation for the treatment of cicatrix, it is held to levy and is: make the A preparation by at least a biological product hyaluronidase, 100010 lactose 600mg.
2. a kind of pharmaceutical preparation for the treatment of cicatrix according to claim 1 is characterized in that:: by Ah assistant's anthracene 100mg, pure water 10mil, make the B preparation.
3. a kind of medicine for the treatment of cicatrix according to claim 1 is characterized in that: Triamcinolone Acetonide 40mg Garden lavender quintessence oil 2000mg.Ethoxylation hydrogenated lanolin 20g makes the C preparation.
4. using method: earlier scar is ceased the A preparation be dissolved in treat in the B preparation to dissolve fully after, solution directly is applied to the cicatrix wound surface, then, use manual massage, usefulness refers to that the strength of abdomen, palm pushes repeatedly at the coating place and rotate poking meridian method.Massage or push more than 15 minutes after each medication.Then, again scar is ceased the C preparation and be applied to the cicatrix wound surface, use manual massage, push repeatedly at the coating place and rotate poking meridian method with the strength that refers to abdomen, palm.Massage or push more than 15 minutes after each medication, be administered once every day, and consumption is decided on the cicatrix area.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510107283A CN100584375C (en) | 2005-12-16 | 2005-12-16 | Formula for treating scar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510107283A CN100584375C (en) | 2005-12-16 | 2005-12-16 | Formula for treating scar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1981865A true CN1981865A (en) | 2007-06-20 |
| CN100584375C CN100584375C (en) | 2010-01-27 |
Family
ID=38164895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200510107283A Expired - Fee Related CN100584375C (en) | 2005-12-16 | 2005-12-16 | Formula for treating scar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100584375C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079809A (en) * | 2015-07-09 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | Composition, preparation, method for preparing same, application and method for applying preparation |
| CN110123819A (en) * | 2019-06-03 | 2019-08-16 | 南阳南石医院 | It is a kind of for treating the drug and device of scar |
-
2005
- 2005-12-16 CN CN200510107283A patent/CN100584375C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079809A (en) * | 2015-07-09 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | Composition, preparation, method for preparing same, application and method for applying preparation |
| CN110123819A (en) * | 2019-06-03 | 2019-08-16 | 南阳南石医院 | It is a kind of for treating the drug and device of scar |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100584375C (en) | 2010-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101632750B (en) | Chinese medicinal composition for replenishing essence, filling marrow, boosting kidney and strengthening yang and preparation method thereof | |
| CN1327892C (en) | External use pain relieving spray liquid | |
| CN102988899B (en) | Traditional Chinese medicine composition used for treating obstruction of breast milk secretion | |
| CN102335231B (en) | Chinese medicinal moisturizing cream for treating chloasma as well as preparation method and application thereof | |
| CN100584375C (en) | Formula for treating scar | |
| CN104706953A (en) | Traditional Chinese medicine preparation for treating chronic cervicitis | |
| CN108686009A (en) | Prevent and/or treat essential oil composition, preparation method, application and the preparation of rhinitis | |
| CN102266408B (en) | Use of gardenia extract and borneol effective ingredients in Chinese medicine preparation for intervening in cutaneous prutitus | |
| CN101926977A (en) | Medicament for expelling wind, removing dampness, activating blood and relieving pain | |
| CN107753921B (en) | Traditional Chinese medicine navel plaster for treating hyperemesis gravidarum | |
| CN111773262A (en) | Acupuncture point combination method for treating cold and acupuncture point patch used cooperatively | |
| CN101129509A (en) | Medicament for treating diseases of genitalia and rectum | |
| CN104800264B (en) | One kind carries medicine acupuncture needle and application thereof | |
| CN105982882A (en) | External-use medicine prepared from optically active material composition and used for treating haemorrhoids and preparation technology of external-use medicine | |
| CN110269926A (en) | Middle benefit gas, which is relaxed, warms up composition and its preparation method and application | |
| CN104257777B (en) | Traditional Chinese medicine composition for treating rhinitis, nasosinusitis and frontal sinusitis and preparation method of traditional Chinese medicine composition | |
| CN108653431A (en) | Prevent pharmaceutical composition, preparation method and applications and the preparation of rhinitis | |
| RU2811254C1 (en) | Method of treating erythematotelangiectatic subtype of rosacea by points | |
| CN109602838A (en) | A kind of Chinese medicine composition and its preparation method and application for treating chronic inflammation | |
| CN103156900B (en) | Safflower medicine aerosol and preparation method thereof | |
| CN108066681A (en) | It is a kind of for mongolian medicine patch of infantile hyperpyrexia and preparation method thereof and application method | |
| RU2810400C1 (en) | Method of treating steroid rosacea by points | |
| CN102743440A (en) | Traditional Chinese medicines for treating femoral head necrosis | |
| CN107441183A (en) | Treat gel foamable composition of gynaecological imflammation and its preparation method and application | |
| RU2286791C1 (en) | Method for cicatrice treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100127 Termination date: 20171216 |